Role of chromosome loss in ras/myc-induced Syrian hamster tumors

• Published in: Cancer research (Chicago, Ill.) Ill.), 1988-03, Vol.48 (6), p.1623-1632
• Main Authors: OSHIMURA, M, KOI, M, OZAWA, N, SUGAWARA, O, LAMB, P. W, BARRETT, J. C
• Format: Article
• Language: English
• Subjects: Animal cells; Animals; Biological and medical sciences; Biotechnology; Cell hybridization, cell fusion, hybridomas; Cell Line; Cell physiology; Cell Survival; Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes; Cell Transformation, Neoplastic; Chromosome Aberrations; Cricetinae; Eukaryotic cell cultures; Fundamental and applied biological sciences. Psychology; Karyotyping; Mesocricetus; Metaphase; Methods. Procedures. Technologies; Molecular and cellular biology; Nucleic Acid Hybridization; Oncogenes; Proto-Oncogene Proteins - biosynthesis; Proto-Oncogene Proteins p21(ras); RNA - analysis; Transfection
• ISSN: 0008-5472; 1538-7445

It has been shown previously that normal Syrian hamster embryo cells are neoplastically transformed by transfection with two cooperating oncogenes, v-myc plus v-Ha-ras. Karyotypic analyses of the cells from the tumors revealed a nonrandom chromosome change, monosomy of chromosome 15. In order to clarify the role of chromosome loss in these tumor cells with defined oncogene alterations, molecular and cytogenetic studies were performed on hybrids between normal Syrian hamster embryo cells and ras/myc tumor cells. Following fusion of the tumor cells with the normal cells which are not immortal, the majority of the cell hybrids senesced after less than or equal to 20 population doublings indicating that immortality was recessive. Some of the hybrids escaped senescence and grew indefinitely. These immortal hybrid cells retained the expected numbers of chromosome 15 indicating that escape from senescence did not involve loss of this chromosome. The tumorigenicity and anchorage-independent growth of the nonsenescent hybrids were still suppressed significantly. In these suppressed hybrid cells, RNAs complementary to the v-Ha-ras and v-myc oncogenes were expressed. Furthermore, radioimmune precipitation with a monoclonal antibody to p21ras of [35S]methionine-labeled cell extracts followed by polyacrylamide gel electrophoresis/sodium dodecyl sulfate electrophoresis showed that the suppressed hybrid cells contained high levels of the mutated ras protein. These results indicate that tumorigenicity is suppressed in the hybrids even though the oncogenes are expressed. When the hybrid cells were passaged, anchorage-independent variants appeared in the cultures. At this time, morphological changes occurred in the cultures and the cells were tumorigenic. Karyotypic analyses of the transformed segregants versus the parental hybrid cells revealed a nonrandom loss of one copy of chromosome 15 in the transformed segregants. No other nonrandom chromosome change was observed. These results suggest that the loss of chromosome 15 results in the loss of a cellular tumor suppressor gene which effects a phenotypic change necessary for expression of neoplastic transformation. In addition, the cellular factors responsible for the senescence of the hybrids may provide another mechanism involved in suppressing tumorigenicity.